Aptevo Therapeutics (APVO) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-87.8
-61.12
-34.43
-7.75

Details

Expected EPS
-37.62
Actual EPS
-40.14
Surprise EPS
-2.52
Surprise Percent
+6.7%

Description

Aptevo Therapeutics (APVO) has reported earnings of -40.14 per share for Q4 2025.

0 Comments

Share your thoughts